Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxycarbamide and L-Carnitine in Severe Sickle Cell Anemia
NCT05081349Phase 4Completed
- Sponsor
- Assiut University
- Start
- Jan 2017
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levocarnitine in sickle cell anemia (SCA), sponsored by Assiut University. Started Jan 2017; status: completed.
02
Drugs
levocarnitine
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT05081349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05081349.